- US-listed companies
- GlucoTrack, Inc.
GlucoTrack, Inc.GCTK
Market cap
$45.1M
P/E ratio
| Dec 31, 2011 | Dec 31, 2012 | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | |
| Cash and cash equivalents (Note 2H) | 2 | 543,411 | 2 | 6 | 608,701 | 148,836 | 53,782 | 97,079 | 418,621 | 10 | 6 | 2 |
| Other current assets | 92,817 | 81,472 | 93,052 | 113,842 | 268,792 | 356,994 | 94,137 | 23,288 | 44,658 | 0 | 0 | 0 |
| Total current assets | 2 | 624,883 | 2 | 6 | 2 | 2 | 1 | 314,145 | 718,042 | 10 | 6 | 2 |
| Operating lease right-of-use assets, net | - | - | - | - | - | - | - | - | 187,232 | 0 | 0 | - |
| Property and equipment, net (Note 3) | 82,868 | 70,200 | 107,209 | 122,491 | 220,463 | 240,452 | 216,746 | 149,779 | 133,795 | 0 | 0 | 0 |
| Restricted cash (Note 2H) | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 |
| TOTAL ASSETS | 2 | 814,571 | 3 | 6 | 2 | 2 | 2 | 688,186 | 1 | 11 | 6 | 2 |
| Accounts payable | 71,763 | 122,537 | 49,787 | 104,711 | 1 | 2 | 2 | 2 | 2 | 1 | 1 | 1 |
| Operating lease liabilities, current | - | - | - | - | - | - | - | - | 142,090 | 0 | 0 | - |
| Other current liabilities (Note 4) | 211,278 | 297,989 | 261,120 | 440,764 | 427,886 | 713,549 | 1 | 1 | 596,087 | 0 | 0 | 0 |
| Total current liabilities | 283,041 | 457,953 | 310,907 | 1 | 2 | 2 | 4 | 3 | 2 | 1 | 1 | 1 |
| Loans from stockholders (Note 5) | 606,144 | 630,575 | 693,092 | 163,459 | 160,314 | 162,034 | 182,767 | 168,221 | 190,365 | 0 | 0 | 0 |
| Operating lease liabilities, non-current | - | - | - | - | - | - | - | - | 45,143 | 0 | 0 | - |
| Total non-current liabilities | - | - | 9 | 2 | 656,146 | 1 | 1 | 339,878 | 421,808 | 0 | 0 | 0 |
| Total liabilities | 1 | 1 | 9 | 3 | 2 | 3 | 5 | 4 | 3 | 2 | 1 | 1 |
| Common Stock of $ 0.001 par value (“Common Stock”):500,000,000 shares authorized; 15,500,730 and 15,470,402 shares issued and outstanding as of December 31, 2022 and 2021, respectively | 5,296 | 5,461 | 5,302 | 5,324 | 5,691 | 6,028 | 6,824 | 141,638 | 162,842 | 0 | 0 | 0 |
| Additional paid-in capital | 13 | 15 | 15 | 18 | 22 | 25 | 31 | 84 | 89 | 102 | 103 | 103 |
| Receipts on account of shares | - | - | - | - | - | - | - | - | - | - | - | 0 |
| Accumulated other comprehensive income (loss) | 22,634 | 8,925 | 52,702 | 66,670 | 90,168 | 62,576 | 110,675 | 164,232 | 124,062 | 0 | -0 | 0 |
| Accumulated deficit | -12,517,519 | -15,289,826 | -25,653,190 | -23,087,063 | -29,376,515 | -35,604,176 | -47,368,612 | -87,186,783 | -90,702,929 | -93 | -97 | -102 |
| Total stockholders’ equity | 968,239 | -503,069 | -11,063,118 | -4,832,203 | -6,970,914 | -10,949,430 | -16,574,933 | -2,873,301 | -1,411,602 | 9 | 5 | 1 |
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | 2 | 814,571 | 3 | 6 | 2 | 2 | 2 | 688,186 | 1 | 11 | 6 | 2 |